Cost-effective alternative to nano-encapsulation: Amorphous curcumin–chitosan nanoparticle complex exhibiting high payload and supersaturation generation
- 1 October 2015
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 96, 1-10
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Curcumin, a component of golden spice: From bedside to bench and backBiotechnology Advances, 2014
- Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatmentBiomaterials, 2014
- Advances in Nanotechnology-Based Delivery Systems for CurcuminNanomedicine, 2012
- Curcumin nanoformulations: a future nanomedicine for cancerDrug Discovery Today, 2012
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdvanced Drug Delivery Reviews, 2011
- Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell modelEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochemical Pharmacology, 2010
- Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancerEuropean Journal of Pharmaceutical Sciences, 2009
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human VolunteersPlanta Medica, 1998